JAKAVI Ruxolitinib 15 mg Tablets
JAKAVI (Ruxolitinib 15 mg Tablets) is an advanced prescription medicine belonging to the class of Janus kinase (JAK1/JAK2) inhibitors. It is primarily used in the treatment of certain blood-related cancers and bone marrow disorders. JAKAVI helps regulate abnormal blood cell production and reduces symptoms such as enlarged spleen, fatigue, night sweats, and weight loss associated with myeloproliferative diseases.
It is widely prescribed in conditions like myelofibrosis, polycythemia vera, and graft-versus-host disease (GVHD) under strict medical supervision.
📌 Contact Details – Place Your Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
🌐 Website: https://globmedindia.com
Composition and Content
- Active Ingredient: Ruxolitinib 15 mg
- Drug Class: Janus Kinase (JAK1 & JAK2) Inhibitor
- Form: Oral Tablets
- Strength: 15 mg per tablet
- Packaging: Usually blister packs (varies by manufacturer)
How to Use
- Taken orally with or without food
- Swallow whole with water
- Should be taken at the same time daily for best results
- Dose adjustments must be done only by a qualified oncologist/hematologist
Recommended Dosage
- Dosage depends on medical condition, platelet count, and response to treatment
- Common regimens are twice daily dosing
- Never self-adjust or stop medication without doctor consultation
Uses of JAKAVI (Ruxolitinib 15 mg)
- Myelofibrosis (primary or secondary)
- Polycythemia Vera (resistant/intolerant cases)
- Graft-Versus-Host Disease (GVHD)
- Reduction of enlarged spleen (splenomegaly)
- Symptom control in myeloproliferative disorders
Treatments Supported
- Blood cancer management therapy
- Bone marrow disorder control
- Immune response regulation in GVHD
- Symptom relief in chronic hematologic conditions
Advantages
- Helps reduce spleen size effectively
- Improves quality of life and energy levels
- Targets abnormal JAK signaling pathway
- Oral tablet convenience (no injection required)
- Clinically proven targeted therapy
Storage Conditions
- Store below 30°C temperature
- Keep in original packaging
- Protect from moisture and direct sunlight
- Keep out of reach of children
- Do not use expired medicine
Alternative Indian Brands / Generic Options
In India, Ruxolitinib generic versions may be available from licensed oncology pharmaceutical companies. Availability can vary, but possible manufacturers or equivalent sources include:
- Licensed Indian oncology drug manufacturers offering Ruxolitinib tablets
- Oncology divisions of major pharma companies (availability subject to regulatory approval)
- Hospital pharmacy generics under prescription supply chain
👉 Always consult a doctor or registered pharmacist for approved equivalent substitution.
Buy JAKAVI Ruxolitinib 15 mg online, Ruxolitinib tablets India, cancer medicine online delivery, myelofibrosis treatment drug, JAK inhibitor tablets India, oncology medicines export, buy anti cancer tablets online, Ruxolitinib 15 mg price India, Jakavi alternative India, targeted therapy cancer drug, global medicine exporter India
🌍 Demand Countries & Cities (Export Focus – South Africa Region)
High demand and supply inquiries for oncology medicines like JAKAVI Ruxolitinib include:
Countries:
- South Africa
- Botswana
- Lesotho
- Mozambique
- Namibia
- Eswatini (Swaziland)
- Zimbabwe
Cities:
- Johannesburg
- Cape Town
- Pretoria
- Polokwane
- Germiston
- Nelspruit
📦 Purchase Today Online – GlobMedIndia
Get fast, safe, and reliable international delivery of oncology medicines including JAKAVI Ruxolitinib 15 mg Tablets from GlobMedIndia – The Medicine Exporter. Trusted sourcing, export support, and global shipping available for prescription-based orders.
